Skip to main content
Clinical Trials/NCT03022110
NCT03022110
Unknown
Not Applicable

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts: A Multi-center Randomized Controlled Trial

Yiqi Du0 sites106 target enrollmentFebruary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Pseudocyst
Sponsor
Yiqi Du
Enrollment
106
Primary Endpoint
Cyst recurrence rate
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to compare the effect of lumen-apposing metal stent (LAMS) and traditional plastic stent on the drainage of pancreatic pseudocyst, mainly to observe the cyst recurrence rate of 12 months after treatment.

Detailed Description

Inclusion criteria 1. Subject with ages from 18-80 years old 2. Subject with pancreatic pseudocysts confirmed by CT 3. Subject with a history of MSAP or SAP, the pseudocysts were formed more than 3 months 4. The size of pseudocyst is more than 6 cm, and the cyst adjacent to the gastric wall 5. Subject has the symptoms related with the pseudocyst 6. The consent form has been signed Exclusion criteria 1. Subject is younger than 18 years or older than 80 years 2. Pancreatic pseudocyst communicate with the main pancreatic duct 3. Subject can't accept the endoscopic procedure 4. Pancreatic pseudocyst with infection or subject diagnosed with pancreatic abscess 5. The distance between gastric and the wall of the pseudocyst is more than 1 cm 6. Subject with 2 or more than 2 cysts 7. Subject has blood coagulation dysfunction 8. Pregnant or subject has mental disorders

Registry
clinicaltrials.gov
Start Date
February 2017
End Date
December 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yiqi Du
Responsible Party
Sponsor Investigator
Principal Investigator

Yiqi Du

Professor

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • Subject with ages from 18-80 years old
  • Subject with pancreatic pseudocysts confirmed by CT
  • Subject with a history of MSAP or SAP, the pseudocysts were formed more than 3 months
  • The size of pseudocyst is more than 6 cm, and the cyst adjacent to the gastric wall
  • Subject has the symptoms related with the pseudocyst
  • The consent form has been signed

Exclusion Criteria

  • Subject is younger than 18 years or older than 80 years
  • Pancreatic pseudocyst communicate with the main pancreatic duct
  • Subject can't accept the endoscopic procedure
  • Pancreatic pseudocyst with infection or subject diagnosed with pancreatic abscess
  • The distance between gastric and the wall of the pseudocyst is more than 1 cm
  • Subject with 2 or more than 2 cysts
  • Subject has blood coagulation dysfunction
  • Pregnant or subject has mental disorders

Outcomes

Primary Outcomes

Cyst recurrence rate

Time Frame: up to 12 months

Secondary Outcomes

  • Complication rate(up to 12 months)
  • Technical success rate(up to 48 hours)
  • Clinical success rate(up to 12 months)

Similar Trials